Summary
We have studied the biochemical effects of high doses of inhaled salbutamol in 14 asthmatic patients age 38 years, FEV1 62%. Cumulative doubling doses of inhaled salbutamol were given every 20 min as follows: 100 µg, 200 µg, 500 µg, 1000 µg, 2000 µg, 4000 µg. Plasma glucose, potassium, and magnesium were measured at each step of the doseresponse curve.
Salbutamol produced significant hypokalaemic and hyperglycaemic effects, but no significant change in magnesium. There were linear log-dose responses for both glucose (r/it=0.58) and potassium (r=−0.46).
There were wide individual variations in maximum responses to salbutamol 4000 µg (as means and 95% confidence intervals): Δ glucose 1.46 (0.83 to 2.09) mmol/l, Δ potassium −0.38 (−0.64 to −0.12) mmol/l.
Thus, hypokalaemic and hyperglycaemic effects may occur with doses of salbutamol similar to those curently used for nebulizer therapy (2.5–5 mg). We postulate that during acute exacerbations of airflow obstruction these changes may be accentuated and become clinically relevant.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bengtsson B, Fagerstrom PO (1982) Extrapulmonary effects of terbutaline during prolonged administration. Chest 31: 726–732
Bos WJW, Postma DS, Van Doormal JJ (1988) Magnesiuric and calciuric effects of terbutaline in man. Clin Sci 74: 595–597
Canepa-Anson R, Dawson JR, Kuan P, Poole-Wilson PA, Sutton GC, Cockrill B, Reuben SR (1987) Differences between acute and long-term metabolic and endocrine effects of oral beta-adrenoceptor agonist therapy with pirbuterol for cardiac failure. Br J Clin Pharmacol 23: 173–181
Collier JG, Dobbs RJ, Williams I (1980) Salbutamol aerosol causes a tachycardia due to the inhaled rather than the swallowed fraction. Br J Clin Pharmacol 9: 273–274
Conolly ME, Greenacre JK (1976) The lymphocyte beta-adrenoceptor in normal subjects and patients with bronchial asthma. J Clin Invest 58: 1307–1316
Davies DS (1975) Pharmacokinetics of inhaled substances. Postgrad Med J 51 [Suppl 7]: 69–75
Davies DS (1984) The fate of inhaled terbutaline. Eur J Respir Dis 65 [Suppl 134]: 141–147
Fraser CG (1986) Biological variation. In: Fraser CG (eds) Interpretation of clinical chemistry laboratory data. Blackwell Scientific, Oxford, pp 111–135
Fraser CG (1988) The application of theoretical goals based on biological variation data in proficiency testing. Arch Pathol Lab Med 112: 404–415
Galant SP, Duriseti L, Underwood S, Allred S, Insel PA (1980) Beta-adrenergic receptors of polymorphonuclear particulates in bronchial asthma. J Clin Invest 65: 577–585
Haalboom JRE, Deenstra M, Struyvenburg A (1985) Hypokalaemia induced by inhalation of fenoterol. Lancet 1: 1125–1127
Harris EK (1979) Statistical principles underlying analytical goal-setting in clinical chemistry. Am J Clin Pathol 72: 374–382
Harvey JE, Baldwin CJ, Wood PJ, Alberti KGM, Tattersfield AE (1981) Airway and metabolic responsiveness to intravenous salbutamol in asthma: Effect of regular inhaled salbutamol. Clin Sci 60: 579–585
Higgins RM, Cookson WOCM, Lane DJ, John SM, McCarthy GL, McCarthy ST (1987) Cardiac arythmias caused by nebulised beta-agonist therapy. Lancet 2: 863–864
Kung M, Croley SW, Phillips BA (1987) Systemic cardiovascular and metabolic effects associated with the inhalation of an increased dose of albuterol: Influence of mouth rinsing and gargling. Chest 91: 382–387
Laros CD, van Urk P, Rominger KL (1977) Absorption, distribution and excretion of the tritium-labelled beta2-stimulator fenoterol hydrobromide following aerosol administration and instillation into the bronchial tree. Respiration 34: 131–140
Levine BS, Coburn JW (1984) Magnesium, the mimic/antagonist of calcium. N Engl J Med 310: 1253–1254
Lipworth BJ, McDevitt DG (1989) Beta-adrenoceptor responses to inhaled salbutamol in normal subjects. Eur J Clin Pharmacol 36: (in press)
Morris HG, Rusnak SA, Selner JC, Barzens K, Barnes JB (1978) Comparative effects of ephedrine on adrenergic responsiveness in normal and asthmatic subjects. J Allergy Clin Immunol 61: 294–302
Neville A, Palmer JBD, Gaddie J, May CS, Palmer KNV, Murchison LE (1977) Metabolic effects of salbutamol: Comparison of aerosol and intravenous administration. Br Med J 1: 413–414
Newman SP, Pavia D, Clarke SW (1980) Simple instructions for using pressurised aerosol bronchodilators. J R Soc Med 73: 776–779
Newman SP, Pavia D, Moten F, Sheahan NE, Clarke SW (1981) Deposition of pressurised aerosols in the human respiratory tract. Thorax 36: 52–55
Nogrady SG, Hartley JPR, Seaton A (1977) Metabolic effects of intravenous salbutamol in the course of acute severe asthma. Thorax 32: 559–562
Nordrehaug JE, Johannessen KA, Von der Lippe G (1985) Serum potassium as a risk factor of ventricular arrhythmias early in acute myocardial infarction. Circulation 71: 645–649
Quamme GA, Dirks JH (1986) The physiology of renal magnesium handling. Renal Physiol 9: 257–269
Ross JW (1982) Evaluation of precision. In: Werner M (ed) CRC handbook of clinical chemistry, vol 1. CRC Press, Boca Raton, pp 391–422
Scheinin M, Koulu M, Laurikainen E, Allonen H (1987) Hypokalaemia and other non-bronchial effects of inhaled fenoterol and salbutamol: A placebo-controlled dose-response study in healthy volunteers. Br J Clin Pharmacol 24: 645–653
Struthers AD, Whitesmith R, Reid JL (1983) Prior thiazide diuretic treatment increases adrenaline-induced hypokalaemia. Lancet 1: 1358–1361
Whyte KF, Addis GJ, Whitesmith R, Reid JL (1987) Adrenergic control of plasma magnesium in man. Clin Sci 72: 135–138
Whyte KF, Reid C, Addis GJ, Whitesmith R, Reid JL (1988) Salbutamol induced hypokalaemia: The effect of theophylline alone and in combination with adrenaline. Br J Clin Pharmacol 25: 571–578
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lipworth, B.J., Clark, R.A., Fraser, C.G. et al. The biochemical effects of high-dose inhaled salbutamol in patients with asthma. Eur J Clin Pharmacol 36, 357–360 (1989). https://doi.org/10.1007/BF00558295
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00558295